Your browser doesn't support javascript.
loading
Epidemiology of aplasia cutis congenita: A population-based study in Europe.
Coi, Alessio; Barisic, Ingeborg; Garne, Ester; Pierini, Anna; Addor, Marie-Claude; Aizpurua Atxega, Amaia; Ballardini, Elisa; Braz, Paula; Broughan, Jennifer M; Cavero-Carbonell, Clara; de Walle, Hermien E K; Draper, Elizabeth S; Gatt, Miriam; Häusler, Martin; Kinsner-Ovaskainen, Agnieszka; Kurinczuk, Jennifer J; Lelong, Nathalie; Luyt, Karen; Mezzasalma, Lorena; Mullaney, Carmel; Nelen, Vera; Odak, Ljubica; O'Mahony, Mary T; Perthus, Isabelle; Randrianaivo, Hanitra; Rankin, Judith; Rissmann, Anke; Rouget, Florence; Schaub, Bruno; Tucker, David; Wellesley, Diana; Wisniewska, Katarzyna; Yevtushok, Lyubov; Santoro, Michele.
Afiliação
  • Coi A; Unit of Epidemiology of Rare Diseases and Congenital Anomalies, Institute of Clinical Physiology, National Research Council, Pisa, Italy.
  • Barisic I; Children's Hospital Zagreb, Centre of Excellence for Reproductive and Regenerative Medicine, Medical School University of Zagreb, Zagreb, Croatia.
  • Garne E; Department of Paediatrics and Adolescent Medicine, Lillebaelt Hospital, University Hospital of Southern Denmark, Kolding, Denmark.
  • Pierini A; Unit of Epidemiology of Rare Diseases and Congenital Anomalies, Institute of Clinical Physiology, National Research Council, Pisa, Italy.
  • Addor MC; Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
  • Aizpurua Atxega A; Department of Woman-Mother-Child, University Medical Center CHUV, Lausanne, Switzerland.
  • Ballardini E; Public Health Division of Gipuzkoa, Biodonostia Research Institute, Donostia-San Sebastian, Spain.
  • Braz P; Neonatal Intensive Care Unit, Paediatric Section, IMER Registry (Emilia Romagna Registry of Birth Defects), Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Broughan JM; Epidemiology Department, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
  • Cavero-Carbonell C; National Congenital Anomaly and Rare Disease Registration Service, National Disease Registration Service, NHS Digital, Leeds, UK.
  • de Walle HEK; Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain.
  • Draper ES; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Gatt M; Department Health Sciences, College of Life Sciences, University of Leicester, Leicester, UK.
  • Häusler M; Malta Congenital Anomalies Registry, Directorate for Health Information and Research, G'Mangia, Malta.
  • Kinsner-Ovaskainen A; Medical University of Graz, Graz, Austria.
  • Kurinczuk JJ; European Commission, Joint Research Centre (JRC), Ispra, Italy.
  • Lelong N; National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Luyt K; Université Paris Cité, Inserm, INRAE, Centre for Research in Epidemiology and StatisticS (CRESS), Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, Paris, France.
  • Mezzasalma L; South West Congenital Anomaly Register, Bristol Medical School, University of Bristol, Bristol, UK.
  • Mullaney C; Unit of Epidemiology of Rare Diseases and Congenital Anomalies, Institute of Clinical Physiology, National Research Council, Pisa, Italy.
  • Nelen V; Department of Public Health, HSE South East, Lacken, Kilkenny, Ireland.
  • Odak L; Provincial Institute of Hygiene, Antwerp, Belgium.
  • O'Mahony MT; Children's Hospital Zagreb, Centre of Excellence for Reproductive and Regenerative Medicine, Medical School University of Zagreb, Zagreb, Croatia.
  • Perthus I; Department of Public Health, HSE South (Cork & Kerry), Cork, Ireland.
  • Randrianaivo H; Auvergne Registry of Congenital Anomalies (CEMC-Auvergne), Department of Clinical Genetics, Centre de Référence des Maladies Rares, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.
  • Rankin J; Register of Congenital Malformations Isle of Reunion Island, CHU St Pierre, la Reunion, Reunion, France.
  • Rissmann A; National Congenital Anomaly and Rare Disease Registration Service, National Disease Registration Service, NHS Digital, Leeds, UK.
  • Rouget F; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Schaub B; Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty Otto-von-Guericke University, Magdeburg, Germany.
  • Tucker D; Brittany Registry of Congenital Anomalies, CHU Rennes, Univ Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, Rennes, France.
  • Wellesley D; French West Indies Registry, Registre des Malformations des Antilles (REMALAN), Maison de la Femme de la Mère et de l'Enfant, University Hospital of Martinique, Fort-de-France, France.
  • Wisniewska K; Congenital Anomaly Register & Information Service for Wales (CARIS), Public Health Wales, Swansea, UK.
  • Yevtushok L; University Hospital Southampton, Faculty of Medicine and Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
  • Santoro M; Epidemiology Unit, Department of Preventive Medicine, Poznan University of Medical Sciences, Poznan, Poland.
J Eur Acad Dermatol Venereol ; 37(3): 581-589, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36300660
ABSTRACT

BACKGROUND:

Aplasia cutis congenita (ACC) is a rare congenital anomaly characterized by localized or widespread absence of skin at birth, mainly affecting the scalp. Most information about ACC exists as individual case reports and medium-sized studies.

OBJECTIVES:

This study aimed to investigate the epidemiology of ACC, using data from a large European network of population-based registries for congenital anomalies (EUROCAT).

METHODS:

Twenty-eight EUROCAT population-based registries in 16 European countries were involved. Poisson regression models were exploited to estimate the overall and live birth prevalence, to test time trends in prevalence between four 5-year periods and to evaluate the impact of the change of coding for ACC from the unspecific ICD9-BPA code to the specific ICD10 code. Proportions of ACC cases associated with other anomalies were reported.

RESULTS:

Five hundred cases were identified in the period 1998-2017 (prevalence 5.10 per 100,000 births). Prevalence across 5-year periods did not differ significantly and no significant differences were evident due to the change from ICD9 to ICD10 in ACC coding. Heterogeneity in prevalence was observed across registries. The scalp was the most common site for ACC (96.4%) and associated congenital anomalies were present in 33.8% of cases. Patau and Adams-Oliver syndromes were the most frequent among the associated chromosomal anomalies (88.3%) and the associated genetic syndromes (57.7%), respectively. 16% of cases were associated with limb anomalies and 15.4% with congenital heart defects. A family history of ACC was found in 2% of cases.

CONCLUSION:

To our knowledge, this is the only population-based study on ACC. The EUROCAT methodologies provide reliable prevalence estimates and proportions of associated anomalies.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatoses do Couro Cabeludo / Displasia Ectodérmica / Deformidades Congênitas dos Membros Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Newborn País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatoses do Couro Cabeludo / Displasia Ectodérmica / Deformidades Congênitas dos Membros Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Newborn País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article